Market access services

Designing Market Access Strategies
  • Negotiating strategy (National & Regional & Local)
    • Align National and Regional priorities
    • Target populations, life-cycle management
  • Elaborate Value Dossier content
    • Incorporate HTA & Payer’s perspective
    • Mock IPT
    • Economic Evaluation & Budget Impact
  • Development phase IV projects (‘beyond the pill’)
    • Managed Entry Schemes and Risk-Sharing Agreements
    • RWD & RWE
  • Engaging stakeholders
Pricing
  • Analyse trends
  • Payer market research
  • Price modelling
    • Price erosion
    • Effect of generics and biosimilars
    • Effect of new entries
  • Life cycle management
  • Negotiation strategy
    • Early access programmes
    • Managed Entry Schemes
Competitive Intelligence
  • Review approval process at the MoH and Regional level
  • Review penetration and Guideline incorporation
  • Benchmark with similar products or diseases
  • Review tendering trends
  • Propose comparative scenarios
Training & Support for Negotiation
  • Training for Market Access teams on
    • Potential hurdles
    • Objection handler
    • Costumer needs
  • Review value stories / presentations to stakeholders to strengthen messages and meet costumer needs
  • Prepare teams on strategy negotiations
    • Flow on clinical & financial deals to be proposed, and how to back them
  • Design of Managed Entry Schemes and Early Access Agreements
We support health start-ups
Early stage